Wei Zhu

9PUBLICATIONS
10CO-AUTHORS
Molecular targetsBiologically active moleculesMolecular medicineMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
Structure-Based Design of Potent TLR7/8/9 Triple Antagonists: Overcoming High Tissue Distribution and Reactive Metabolite Liabilities.

|Apr 20, 2026
Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy.

|Apr 08, 2025
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor Efficacy.

Bo Chen, Xiaofeng Liu, Tong Mu

|Oct 06, 2023
Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.

Buyu Kou, Zhisen Zhang, Xingchun Han

|Mar 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection.

Weixing Zhang, Lei Guo, Haixia Liu

|Aug 14, 2020
Discovery of Pyrido[2,3-b]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IV.

Yimin Hu, Houguang Shi, Mingwei Zhou

Pageof 2

Frequent Collaborators

8 joint publications

Hong C Shen

3 joint publications

Xuefei Tan

2 joint publications

Guozhi Tang

2 joint publications

Haixia Liu